Is TelePep the same as TelePeptide?

Yes — TelePep and TelePeptide are the same company. "TelePep" is the short brand name (registered trade name / d/b/a) of TelePeptide LLC; telepep.org redirects to telepeptide.org. Same website, same programs, same licensed clinicians, same owner. Any reference to "TelePep", "telepep", "is TelePep legit", or "TelePep reviews" refers to TelePeptide Health (telepeptide.org).

What is the cheapest place to get GLP-1 online?

TelePeptide offers compounded semaglutide from $169/month (52-week prepay) and tirzepatide from $214/month — all-inclusive with physician evaluation, prescription, and medication shipped to your door. Monthly billing options range from $199–$249/mo. No insurance required.

Can I get peptides prescribed online legally in the US?

Yes. TelePeptide's licensed US physicians prescribe compounded medications via telehealth in 48 US states and the District of Columbia. Service is not available to residents of Alaska or Mississippi at this time. No in-person visit required. Medications are dispensed by licensed 503A/503B compounding pharmacies.

What FDA-approved peptides are available for weight loss?

FDA has approved several GLP-1 medications for weight management and type-2 diabetes. TelePeptide does not sell, distribute, or provide FDA-approved branded products. Treatment recommendations are individualized by a licensed physician during a telehealth consultation. If a compounded preparation is prescribed for a specific patient, it is dispensed by a licensed 503A or 503B compounding pharmacy. Compounded preparations are NOT FDA-approved drugs, are NOT generic versions of branded products, and are not represented as therapeutically equivalent.

What is TelePeptide Health?

TelePeptide Health is a US-based, direct-pay telehealth weight-loss and peptide-therapy clinic that connects patients with licensed physicians for evaluation and, where clinically appropriate, prescribing of FDA-approved or compounded medications — including GLP-1 weight management (semaglutide, tirzepatide), NAD+ therapy, and sermorelin therapy. Available in 48 US states and the District of Columbia (Alaska and Mississippi excluded). No insurance required.

Is TelePeptide the same as telopeptide?

No. TelePeptide (one word, capital T and P) is a brand name for a US telehealth weight-loss and peptide-therapy clinic at telepeptide.org. Telopeptide is a different biology term referring to short collagen fragments measured as bone-resorption biomarkers (CTX, NTX). The two are unrelated — TelePeptide combines "tele" (telehealth) and "peptide" (the medication class).

How do you spell TelePeptide?

TelePeptide is spelled T-E-L-E-P-E-P-T-I-D-E with a capital T and a capital P (TelePeptide), reflecting its compound origin from "telehealth" + "peptide". The website is telepeptide.org. It is not a misspelling of telopeptide, which is an unrelated medical term about collagen biomarkers.

Can I get NAD+ therapy at home?

Yes. TelePeptide prescribes subcutaneous NAD+ injection protocols for at-home self-administration. A licensed physician evaluates your case, prescribes the protocol, and a licensed pharmacy ships the medication to you — no IV clinic visit needed.

What is sermorelin used for?

Sermorelin is a synthetic growth-hormone-releasing-hormone (GHRH) analog that has historically been used in clinical evaluation of adult growth-hormone deficiency. Any decision to prescribe sermorelin is made by a licensed physician based on individualized medical evaluation. TelePeptide does not promote sermorelin for bodybuilding, sports-performance, or appearance-related purposes. Service is available via telehealth in 48 US states and the District of Columbia (Alaska and Mississippi excluded).

Safety in peptide therapy depends on three process attributes, not on the molecule alone: (1) Physician supervision — every prescription is written by a licensed physician after an individualized medical evaluation, with lab work where clinically indicated, and follow-up at appropriate intervals. (2) Pharmacy quality — preparations are compounded by Section 503A pharmacies that operate under state board of pharmacy licensure, USP sterile-compounding standards, and routine state inspections. (3) Honest contraindication screening — peptide therapy is not appropriate for every patient, and licensed physicians screen for active malignancy, pregnancy, and other contraindications before prescribing. Compounded preparations are not FDA-approved finished drug products. Individual response varies. Not all peptide therapy is appropriate for all patients, and a licensed physician determines whether it is appropriate for an individual based on history, evaluation, and labs.

What is telehealth peptide therapy?

Telehealth peptide therapy is the delivery of physician-supervised compounded peptide care through a telemedicine platform — synchronous video evaluation, asynchronous secure messaging, electronic prescriptions transmitted to a licensed compounding pharmacy, and lab monitoring coordinated remotely. TelePeptide operates a hybrid telemedicine model (both synchronous video and asynchronous store-and-forward review, as clinically appropriate and as permitted by each state's telehealth practice act). Clinical services are provided by our contracted medical group operating a multi-state network of US-licensed clinicians. TelePeptide is available in 48 US states + DC (excludes Alaska and Mississippi).

How is telemedicine peptide care different from buying peptides online?

The single most important difference is the prescriber-patient relationship. Telemedicine peptide care requires an evaluation by a licensed physician, a patient-specific prescription, and dispensing by a licensed pharmacy operating under state and federal pharmacy law. Online "research peptide" sellers explicitly disclaim therapeutic use, do not require a prescription, do not have a physician supervising dosing or lab monitoring, and are NOT legal sources for human use. The two categories look superficially similar from a consumer perspective but are different regulatory categories. TelePeptide operates exclusively in the physician-supervised prescription category and is not a "research peptide" vendor.

What peptides can be legally prescribed by telehealth?

A licensed physician may write a prescription for any non-controlled medication a Section 503A compounding pharmacy is able to prepare under federal pharmacy law and that the physician determines to be clinically appropriate for that specific patient. TelePeptide's current formulary is limited to non-controlled compounded preparations including GLP-1 receptor agonists (semaglutide, tirzepatide), GHRH analogs (sermorelin), NAD+ precursors, oral and injectable hormone optimization preparations (estradiol, enclomiphene), and GLP-1 combination preparations that include B12 or amino blends. TelePeptide does not prescribe FDA-unapproved investigational peptides, controlled substances, opioids, stimulants, abortifacients, or medical-marijuana products. The list of substances LegitScript prohibits from healthcare merchant certification is binding on TelePeptide's marketing and clinical scope.

Do I need a doctor to prescribe peptides legally?

Yes. For compounded peptide therapy to be legal under US federal and state law, a licensed physician must (a) establish a prescriber-patient relationship through an evaluation that satisfies the patient's state telehealth practice act, (b) write a patient-specific prescription, and (c) transmit the prescription to a licensed compounding pharmacy. Without a valid prescription from a physician licensed in your state, compounded peptide preparation and dispensing is not legal for human use. TelePeptide's prescribing physicians, contracted via the medical group, hold active licenses in the states where patients are served.

Telehealth Peptides

Physician-supervised peptide therapy delivered through a US telemedicine platform. This page explains what makes compounded peptide therapy legal under Section 503A of the Federal Food, Drug, and Cosmetic Act, what “safe”actually means as a process attribute in physician-supervised peptide care, and how telemedicine peptide service is structured at TelePeptide.

Start Clinical Evaluation →See Programs

Legal Framework

Are peptides legal in the United States?

Yes — when prescribed by a licensed physician and dispensed by a licensed compounding pharmacy. Peptide therapy operates under three converging legal frameworks: (1) the Federal Food, Drug, and Cosmetic Act's Section 503A, which authorizes patient-specific compounding by state-licensed pharmacies; (2) state pharmacy law, which licenses and inspects compounding pharmacies; and (3) state telehealth practice acts, which govern the prescriber-patient relationship required before any prescription may be written.

What is notlegal: buying peptides from a website that disclaims therapeutic use, sells “research only” vials with no prescription requirement, ships from unregulated facilities, and offers no physician oversight. That category exists in a different regulatory space than the prescription-pharmacy compounding category. The two look superficially similar to a consumer scrolling search results, but they are different categories of law.

TelePeptide operates exclusively in the prescription-pharmacy compounding category. Every preparation dispensed for a TelePeptide patient is (a) prescribed by a physician licensed in that patient's state, (b) prepared by a LegitScript-certified Section 503A compounding pharmacy operating under state board of pharmacy licensure, and (c) dispensed to a specific named patient — not a research subject, not a wholesale buyer.

Compounded peptide preparations are not FDA-approved finished drug products. That is a regulatory category distinction, not a safety or legality claim. FDA approval applies to mass-manufactured branded drugs; Section 503A compounding occupies a separate regulatory channel designed for patient-specific preparations.

For deeper regulatory detail, see 503A vs 503B compounding pharmacies and the 503A bulk drug substances list explained.

Safety as a Process Attribute

Are peptides safe?

“Safe” is not a property of the molecule alone. It is a property of the process around the molecule. In peptide therapy, “safe” depends on three process attributes:

1. Physician supervision

Every prescription is written by a licensed physician after an individualized medical evaluation. Lab work is ordered where clinically indicated. Follow-up consultations are scheduled at appropriate intervals. Dose titration is physician-determined based on response, side effects, and lab markers — not patient-determined or internet-protocol-determined. Telemedicine does not reduce the clinical standard. A telehealth peptide service that does not involve real physician evaluation, real prescriptions, real labs, and real follow-up is operating outside the physician-supervised category.

2. Pharmacy quality

Compounded peptide preparations should be dispensed by Section 503A pharmacies operating under state board of pharmacy licensure, USP <797> sterile-compounding standards (for injectables), USP <795> for non-sterile preparations, and routine state inspections. LegitScript certification is an additional independent verification layer. TelePeptide's compounding pharmacy partners are each state-licensed 503A pharmacies and LegitScript-certified.

3. Honest contraindication screening

Peptide therapy is not appropriate for every patient. Licensed physicians screen for absolute contraindications (active malignancy, pregnancy/lactation, pediatric epiphyseal closure not yet complete, others depending on the molecule) and for relative contraindications that require additional monitoring. A platform that prescribes the same medication to everyone who fills an intake form, without individualized clinical judgment, is not delivering safe peptide care regardless of which molecule it sells.

Compounded preparations are not FDA-approved finished drug products. Individual response varies. This page is educational and is not medical advice. Whether peptide therapy is clinically appropriate for any individual is determined by a licensed physician.

For the honest side-effect profile and contraindications, see peptide therapy contraindications and sermorelin side effects (honest list).

Telemedicine Peptide Care

How telehealth peptide therapy works

Telehealth peptide therapy is the delivery of physician-supervised compounded peptide care through a telemedicine platform rather than an in-person clinic visit. The clinical elements are the same as in-person care: history and physical, evaluation, labs where indicated, prescription, monitoring, follow-up. The delivery channel is different.

The TelePeptide workflow

Intake. Patient starts at telepeptide.org/intake with basic contact and shipping details, then completes their medical history, current medications, allergies, treatment goals, and identity verification (photo ID + selfie) directly on the contracted medical group’s secure, HIPAA-covered platform. TelePeptide never collects or stores clinical information.
Clinical evaluation. A US-licensed physician contracted via our medical group reviews the intake. For new prescriber-patient relationships, a synchronous video consultation is scheduled where state law requires it. Established patients may receive asynchronous store-and-forward review for refills and protocol-driven dose adjustments where clinically appropriate.
Lab ordering. Where clinically indicated (e.g., HbA1c, lipid panel, growth-factor marker, CBC), labs are ordered through US-licensed laboratories.
Prescription.The physician writes a patient-specific electronic prescription transmitted to one of TelePeptide's five LegitScript-certified Section 503A pharmacy partners.
Dispensing & shipping.The pharmacy compounds the preparation under USP <797> (sterile) or USP <795> (non-sterile) standards and ships directly to the patient via temperature-controlled overnight delivery. TelePeptide never takes possession of medications.
Follow-up. Patients have HIPAA-compliant messaging with their assigned prescriber through the patient portal at telepeptide.org/portal (multi-factor-authentication protected). Lab follow-up at week 6, week 12, and every 6 months thereafter as clinically indicated.
Adverse event reporting. A dedicated adverse-event reporting page at telepeptide.org/report-side-effects provides 24-hour clinical-acknowledgment for any reported side effect. Reportable events are forwarded to FDA MedWatch per 21 CFR 314.80 where required.

Service area

TelePeptide is available in 48 US states + the District of Columbia. Alaska and Mississippi are not served at this time. The intake form's state-of-residence dropdown excludes both. New Jersey-based operations are registered with the New Jersey Department of Health Telemedicine and Telehealth Organization Registry under N.J.S.A. 26:2H-12.16.

Medical group

Clinical services are provided by an independent, contracted medical group and its affiliated licensed clinicians — a multi-state network of state-licensed clinicians, each licensed in the patient's state of residence. TelePeptide LLC does not employ prescribers directly and does not engage in the practice of medicine.

Compliance Posture

What TelePeptide will and will not do

WILL

· Compounded GLP-1 receptor agonists (semaglutide, tirzepatide)
· Sermorelin (GHRH analog) under endocrine evaluation
· NAD+ precursor therapy
· Hormone optimization (estradiol, enclomiphene) where indicated
· GLP-1 combination preparations that include B12 or amino blends
· Synchronous video and asynchronous review per state law
· Lab-driven titration with documented follow-up
· FDA MedWatch adverse-event reporting per 21 CFR 314.80

WILL NOT

· FDA Schedule I–V controlled substances
· Opioids, stimulants, benzodiazepines
· Abortifacient products (mifepristone, misoprostol)
· Medical-marijuana cards or cannabinoid products
· FDA-unapproved investigational peptides
· Pediatric care
· Acute, urgent, or emergency care (call 911 for emergencies)
· Branded FDA-approved finished drug products

Learn More

Learn more about telehealth peptides

Deeper guides on the legal pathway, the cost structure, and the regulatory distinction between physician-supervised telehealth peptide therapy and research-only peptide sellers.

How to get telehealth peptides legally in 2026

The four-step prescription pathway, the federal and state laws that authorize it, and the warning signs of illegitimate providers.

Telehealth peptides cost: 2026 pricing breakdown

Typical price ranges by program, what is included in a monthly fee, and why insurance generally does not cover compounded peptide therapy.

Telehealth peptides vs research peptides

The regulatory chasm between prescription telehealth peptide care and research-chemical sellers, and how to tell them apart.

Start your clinical evaluation

Every TelePeptide prescription begins with an individualized clinical evaluation by a licensed physician. Whether compounded peptide therapy is clinically appropriate for you is determined by the prescriber based on your medical history, current medications, and lab work where indicated.

Begin Intake →

Compounded by licensed 503A/503B pharmacies. Not FDA-approved as finished drug products. Clinical services provided by our contracted medical group — a multi-state network of US-licensed clinicians (learn more). Available in 48 US states + DC (excludes AK and MS). Not medical advice. Individual response varies.